NDC 72618-3000

NURTEC ODT

Rimegepant Sulfate

NURTEC ODT is a Oral Tablet, Orally Disintegrating in the Human Prescription Drug category. It is labeled and distributed by Biohaven Pharmaceuticals, Inc. The primary component is Rimegepant Sulfate.

Product ID72618-3000_965a1ac5-b0c6-48a8-a63a-311c73baeac6
NDC72618-3000
Product TypeHuman Prescription Drug
Proprietary NameNURTEC ODT
Generic NameRimegepant Sulfate
Dosage FormTablet, Orally Disintegrating
Route of AdministrationORAL
Marketing Start Date2020-03-05
Marketing CategoryNDA / NDA
Application NumberNDA212728
Labeler NameBiohaven Pharmaceuticals, Inc
Substance NameRIMEGEPANT SULFATE
Active Ingredient Strength75 mg/75mg
Pharm ClassesCalcitonin Gene-related Peptide Receptor Antagonist [EPC],Calcitonin Gene-related Peptide Receptor Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 72618-3000-2

1 BLISTER PACK in 1 CARTON (72618-3000-2) > 75 mg in 1 BLISTER PACK
Marketing Start Date2020-03-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72618-3000-2 [72618300002]

NURTEC ODT TABLET, ORALLY DISINTEGRATING
Marketing CategoryNDA
Application NumberNDA212728
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2020-03-05

Drug Details

Active Ingredients

IngredientStrength
RIMEGEPANT SULFATE75 mg/75mg

OpenFDA Data

SPL SET ID:9ef08e09-1098-35cc-e053-2a95a90a3e1d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2282313
  • 2282320
  • UPC Code
  • 0000000000000

  • Trademark Results [NURTEC ODT]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    NURTEC ODT
    NURTEC ODT
    88840180 not registered Live/Pending
    Biohaven Pharmaceutical Holding CompanyLtd.
    2020-03-19

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.